Fig. 2
From: A novel in-vitro expression assay by LC/MS/MS enables multi-antigen mRNA vaccine characterization

Spiking Study of Four Recombinant Flu Hemagglutinin and Covid Spike Antigens Using Various MS Parameters. (A) LC-PRM profile of four recombinant influenza hemagglutinin (HA) proteins (Wisconsin, Darwin, Austria, and Phuket) and recombinant SARS-CoV-2 S1 domain of spike protein at 2 pmol each spiked into negative control HEK293T cell pellets. (B) Quantitation results of spike study at high resolution (method 1). Antigen peptide signal (%) for each unique antigen relative to specific HEK293T peptide signal at each spike level were plotted and fit with linear curve. The fit slope and R2 value for each antigen are provided in the table below. Orange: Covid; Black: Austria; Blue: Wisconsin; Magenta: Phuket; Red: Darwin. (C) Representative PRM profile of Wisconsin HA peptide EQLSSVSSFER at 0.13 and 2 pmol spike-in levels using high (method 1), medium (method 2), and low (method 3) resolution settings. (D) Quantitation results of spike study at medium resolution (method 2). Antigen peptide signal (%) for each unique antigen relative to specific HEK293T peptide signal at each spike level were plotted and fit with linear curve. The fit slope and R2 value for each antigen are provided in the table below. Orange: Covid; Black: Austria; Blue: Wisconsin; Magenta: Phuket; Red: Darwin.